KRAS inhibitors are raising hopes, says clinical trial investigator Brian Wolpin
Approach builds on prime editing, advances journey toward universal gene therapies
Findings from nearly 1 million heart cells could inform more precise treatments
“This is not a time that we should be pulling back,” says Catherine Wu
Findings in mice suggest blocking protein can reduce resistance to immune checkpoint inhibitors
Study finds mutations in two genes that disrupt ability of cilia to clear mucus in lungs
Genetic variants may drive visible changes in the spleen that contribute to heart disease
Findings deepen understanding of what drives infection, could inform new therapies
Microbes help break down rocks, capture carbon dioxide
Leads include stem cell biologist Paola Arlotta, biomedical AI researcher Marinka Zitnik
Study shows xenotransplantation can serve as a bridge for patients with end-stage kidney disease
Program offers HMS postdoctoral fellows cross-training at intersection of academia, industry